Vanguard Group Inc. raised its stake in shares of DURECT by 3.3% in the second quarter. Vanguard Group Inc. now owns 5,368,184 shares of the specialty pharmaceutical company's stock worth $8,374,000 after buying an additional 169,226 shares during the ...
more»